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Abstract
Objective-To monitor trends in mortality and
morbidity due to ischaemic heart disease and
compare these with observed levels of risk factors
from population surveys.
Design-Analysis of trends in death rates from
ischaemic heart disease in Iceland compared with
expected rates computed from population surveys.
Risk factor levels together with 03 factors obtained
from Cox's regression analysis were used to
compute expected death rates. Trends in morbidity
due to acute myocardial infarction were assessed
and secular trends in dietary consumption compared
with trends in cholesterol concentrations.
Setting-Reykjavik, Iceland (total population
250 000; over half the population live in Reykiavik).
Subjects-12814 randomly selected residents in
the Reykjavik area aged 45-64 (6623 men, 6191
women; 72% and 80% of those invited).
Main outcome measures-Age adjusted rates of
myocardial infarction and deaths from ischaemic
heart disease. Expected risk from risk factor levels
(smoking, total serum cholesterol concentration,
systolic blood pressure) at each unique survey visit.
Results-Mortality from ischaemic heart disease
has decreased by 17-18% since 1970. During 1981-6
the myocardial infarction attack rate in men under 75
decreased by 23%. A decrease occurred in the level
of all three major risk factors after 1968. The fall in
the serum cholesterol concentration coincided with
a reduction in consumption of dairy fat and mar-
garine. The calculated reduction in risk for the age
group 45-64 was about 35%, which was closely
similar to the observed decrease in mortality due to
ischaemic heart disease in that age group.
Conclusion-The reduction in mortality from
ischaemic heart disease was substantially due to a
decreased incidence of myocardial infarction and
could be attributed largely to the reduction in risk
factors.
Introduction
The mortality from ischaemic heart disease has been
declining in some countries and holding steady in
others, but in a few countries it continues to rise.' Time
trends or secular trends in ischaemic heart disease
mortality have been difficult to analyse because they
are usually based on mortality statistics with little or
no information about the individual changes in the
pattern of risk factors.
Mortality from ischaemic heart disease in Iceland is
similar to that in other Scandinavian countries.' We
have analysed the trends in mortality and morbidity
due to ischaemic heart disease in Iceland in relation to
changes in (a) the three major risk factors for the
disease as documented in population surveys from
1968 to 1988-namely, smoking, total serum choles-
terol concentration, and systolic blood pressure-and
(b) the consumption of saturated fats.
Subjects and methods
ASCERTAINMENT OF MORTALITY FIGURES
Information was obtained from all death certificates
from 1951 to 1988 on file in the Statistical Bureau of
Iceland by using the following codes of the Inter-
national Classification of Diseases: 1951-60, ICD (sixth
revision) code 420; 1961-70, ICD (seventh revision)
code 420; 1971-80, ICD (eighth revision) codes
410-413; 1981-8, ICD (ninth revision) codes 410-414.
These codes have been suggested to be the -most
equivalent for ischaemic heart disease in the different
editions.2 All death certificates were reviewed and
coded by an official pathologist. Necropsy had been
carried out in 30-40% of cases.
REGISTER OF MYOCARDIAL INFARCTION 1981-6
During 1981-6 all episodes of acute myocardial
infarction in people aged 25-74 anywhere in Iceland
were registered by the Icelandic study group of
the World Health Organisation's MONICA project
(multinational monitoring of trends and determinants
of cardiovascular disease).3-5 Diagnostic criteria
included symptoms, electrocardiograms, enzyme
activities, and necropsy findings compatible with
definite or possible myocardial infarction (category I or
II).4 External quality control of event registration
was performed by the WHO's reference centre in
Dundee. Registrations included all occurrences of
acute myocardial infarction (and sudden ischaemic
cardiac death), but also, as separate categories, first
and recurrent infarctions (more than 28 days apart).
The proportion of cases excluded because of inade-
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quate data was 2%. Only data for men were used in this
analysis because of the small number of coronary
episodes among women.
SECULAR TRENDS IN RISK FACTORS 1968-88
The Icelandic Heart Association Research Centre
has been conducting a prospective population survey
in Reykjavik since 1968 (Reykjavik study). Over half
of the quarter of a million population of Iceland live in
the Reykjavik area. Icelanders, however, are almost
homogeneous ethnically (of Nordic origin) and have
closely similar living habits (and risk factor levels;
unpublished results). The standard of living in Iceland
has been increasing steadily during the observation
period and is comparable with that in other Scandina-
vian countries. This study examines the three main
factors found to be associated with increased risk of
ischaemic heart disease death in the Icelandic popu-
lation6 (unpublished results)-namely, total serum
cholesterol concentrations, smoking, and systolic
blood pressure.
Data were obtained at baseline in stages I-IV of the
Reykjavik study on a random sample of the general
population in the area. The participation rate was 72%
and 80% of the men and women invited. In addition,
data from the MONICA risk factor surveys in
Iceland during 1983 (survey I) and 1988 (survey II),
also conducted by the Icelandic Heart Association
Research Centre, were used (table I). Each survey
sample comprised a unique group of participants. The
age group 45-64 years was chosen as it was common to
all these surveys. Age adjustment was performed by
using the mean of the age specific values for the four
five year age groups. Each of the four age groups was
examined and the trends found to be similar.
Total serum cholesterol concentration was measured
after overnight fasting. In stages of I-IV at the Reyk-
TABLE I-Numbers ofmen and women aged 45-64 who participated in
population surveys in Iceland during 1968-88
Men Women
Year of Year of
Survey examination No examination No
Reykjavik study stage I 1968 1416 1969 1535
Reykjavik study stage II 1970-1 1599 1971-2 1756
Reykiavik study stage III 1974-6 1646 1976-8 739
Reykjavik study stage IV 1979-81 1089 1982-3 1228
MONICA I 1983 444 1983 468
MONICA II 1988 429 1988 465
javik study and in MONICA I cholesterol was deter-
mined by a chemical colorimetric method (Technicon
autoanalyser method -N-24a).7 In MONICA II an
automated enzymatic method was used (RocheMA 30;
Cobas, Mira). In 250 serum samples subjected to
both methods of measurement results showed close
agreement, the mean total cholesterol concentration
being 6-37 mmol/l by the chemical method and
6 33 mmol/l by the enzymatic method (r=0 93).
Internal and external laboratory quality controls were
used.
Systolic blood pressure was measured by a mercury
sphygmomanometer (Erka) after five minutes' rest.
Information on smoking habits and use of antihyper-
tensive agents was obtained from a health question-
naire.'
The predicted risk associated with each risk factor
was calculated from (a) PI coefficients (see table II)
derived from multivariate analysis using Cox's pro-
portional hazard model9 of survival in an Icelandic
prospective population survey (1968-85; comprising
15 000 men and 16 000 women, of whom 493 and 104
respectively died of ischaemic heart disease) and (b)
the level of these risk factors for each person in the
first examination at the Icelandic Heart Association
Research Centre6 (unpublished results).
SECULAR TRENDS IN DIETARY FAT CONSUMPTION
A national survey showed that milk, butter, other
dairy products, margarine, meat, and meat products
together contribute 90% of saturated fat in the Ice-
landic diet.'0 In this study changes in the consumption
of these foods were assessed on the basis of annual sales
and production records from the Agricultural Produc-
tion Board (dairy and meat products)" and annual
production records from the Statistical Bureau of
Iceland (margarine).12 These data reflect actual con-
sumption as Iceland is totally self sufficient in these
products and prohibits all import of meat and dairy
products. Furthermore, all food exports and reserves
were excluded from these data. No imports or exports
of margarine occurred during the years covered by the
study. Finally, dietary fat from these products was
calculated by using Icelandic food composition tables.
STATISTICS
Secular trends during a defined period were deter-
mined by linear regression. Levels of significance were
computed with two tailed t tests. In establishing
TABLE II-Major risk factors for ischaemic heart disease deaths in Icelandic mnen and women aged 45-64 examined dunrng 1968-88 (men) and 1969-88 (women)
Smoking
Smokers Relative risk
explained by risk
% % % Smoking 1/24 % Taking Mean serum factors*
Years of Never Former cigarettes daily or % Smoking e25 Mean systolic blood antihypertensive cholesterol (95% confidence
Survey examination smokers smokers cigars or pipe cigarettes daily pressure (mm Hg) drugs (mmol/l) interval)
Men
Reykjavik study stage I 1%8 19-0 22-9 53 5 4-6 139-2 5-9 6 65 1 00
ReykjavikstudystageII 1970-1 22 1 22-7 51-0 4-3 149 4 4-3 6-47 1-01 (0-94to 1-08)
ReykjavikstudystageIII 1974-6 22-4 23-0 49 0 5-5 143-8 6-7 6-46 0-94(0-88to 1 00)
Reykjavik study stage IV 1979-81 16 4 26-6 44-0 13-0 135-3 8-5 6 17 0-80 (0-72 to0-88)
MONICA I 1983 26-9 37-5 30 4 5-2 130-1 10-8 6-38 0-72 (0-67 to 0 79)
MONICAII 1988 345 329 254 72 131-3 12-6 6 18 067(0-62to073)
Change in risk factor over 20 yearst 12-0 13-7 -29-3 3-6 -15-5 7-4 -0-42
CoefficientfromCox'sregression 0 0 34 0-79 1-07 0-012 0-64 0-366
% Change in explained risk -13 -17 7 -14 -34
Women
Reykjavik study stage I 1969 43-4 13-0 41-5 2-0 141-9 7.9 7 16 1 00
Reykjavik study stage II 1971-2 46-9 11-9 39-7 1i5 149-6 10-3 6-94 109 (0-97 to 1-22)
Reyk'avikstudystageIII 1976-8 44-1 14-9 38-2 2-7 130-1 10-1 6 61 0-72(0-66to0-79)
Reykjavik study stage IV 1982-3 40-0 16 4 38-6 4 9 129-8 11-3 6-28 0-69 (0-62 to 0-77)
MONICA I 1983 46-0 21-1 31-7 1-2 129-3 18-8 6-74 0 70 (0-63 to078)
MONICAII 1988 52-5 17-0 28-6 2-2 128-9 17-2 6-38 0-64(0-56toO-73)
Change in risk factor over 19 yearst 4-5 6-7 -11-8 0-8 -19 3 9-5 -0 75
fiCoefficient from Cox's regression 0 0-19 1-06 1-98 0-014 0-64 0-25
% Change in explained risk - 8 -24 8 - 17 -37
*Relative risk compared with group examined in 1%8 (men) and 1969 (women). tComputed by linear regression.
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confidence intervals for rates and ratios between rates
their logarithm was assumed to follow the normal
distribution and its variance estimated as the sum of
reciprocals ofthe underlying number of individuals.1'15
Variance of the estimates of risk explained by the risk
factors was computed directly from the risk in the
individuals in each survey. The risk in each individual
was computed relative to the risk in a person having
never smoked, not taking antihypertensive drugs,
having a total serum concentration cholesterol of
6 5 mmol/l, and having a systolic blood pressure of
140 mm Hg.
Results
MORTALITY FIGURES
Figure 1 shows the secular trends from 1951 to 1988
of death rates in Iceland due to ischaemic heart disease
age standardised to the world population. 5 The
maximum rate was reached after 1965 for both sexes
and rates then remained steady until after 1985.
A significant reduction occurred during 1986-8
compared with 1981-5-namely, a 17% reduction
among men and a 12% reduction among women. The
death rate during 1986-8 was similar to that in the early
1960s. In women mortality fell by 18% between 1970
and 1986-8. Analysis of age specific mortality showed
that this reduction had already occurred during 1980-5
in age groups under 75 but no decrease occurred in the
oldest age groups (data not shown).
1951-5 1956-0 1961-5 1966-70 1971-5 1976-80 1981-5 1986-8
Years
FIG 1-Ischaemwc heart disease mortality in Iceland during 1951-88
standardised to world population and expressed per 100000 popula-
tion yearly. Bars are 95% confidence intervals
MYOCARDIAL INFARCTION 1981-6
Time trends in rates for myocardial infarction
during 1981-6 were calculated from the regression lines
shown in figure 2. The attack rate of myocardial
infarction in men aged 25-74 decreased by 23%
(p=0 02), the incidence rate of myocardial infarction
by 19% (p=0 015), and the total death rate from
ischaemic heart disease (myocardial infarction plus
sudden ischaemic cardiac death) by 34% (p=004) (fig
2). The case fatality rate for men was 45% (194/432) in
1981 and 36% (125/343) in 1986, but this difference
was not significant (p=0-14). Episodes of recurrent
myocardial infarction did not decrease significantly
more than the incidence of myocardial infarction (30%
v 19%; p=0-35).
SECULAR TRENDS IN RISK FACTOR LEVELS 1968-88
Table II shows that there was a gradual improve-
ment in all three risk factors over time for both
sexes. Thus the mean serum cholesterol concentration
decreased by 0-42 mmol/l (6-3%) for men and
0 75 mmol/l (10 5%) for women according to the
regression line. The prediction values of the main risk
factors were estimated by using Cox's proportional
hazard model on survival from the Reykjavik study
1oo0j
1981 1982 1983 1984 1985 1986
Year
FIG 2-Myocardial infarction registration during 1981-6 among
Icelandic men aged 25-74. Rates expressed per 100000 yearly. Bars
are 95% confidence intervals. Dotted lines are fitted regression lines.
CI=Confidence interval
1968-856 (unpublished results). According to that
model the observed reduction in cholesterol concentra-
tion should reduce the risk of death from ischaemic
heart disease by 14% in men and 17% in women.
Mean systolic blood pressure decreased by 15-5 and
19 3 mm Hg in men and women, respectively, the risk
of death from ischaemic heart disease decreasing by
17% and 24% according to the model. The proportion
of subjects taking antihypertensive medication
increased considerably. This treatment, however,
seems to have offset the beneficial effects of lowering
high blood pressure by one third, as has been reported
in other prospective studies. (This finding is largely
unexplained but might be related to more severe and
longstanding hypertension in the treated cases.)'6
There was an overall decrease in smoking (though no
fall at all in the proportion of heavy smokers), and this
reduction decreased the risk of death from ischaemic
heart disease by 8% in women and 13% in men.
Figure 3 shows the secular patterns in total risk
attributed to the three risk factors and death rates from
ischaemic heart disease observed in men and women
aged 45-64. The total risk attributed to the three risk
factors decreased from the beginning of the 1970s and
declined by 34-37% by 1988. This decrease in total risk
corresponded closely to the observed decline in the
death rate from ischaemic heart disease in the groups.
For women the two curves coincided, but there was a
lag of several years for men.
TRENDS IN FOOD CONSUMPTION
Patterns of food consumption changed considerably
in Iceland during the observation period, resulting in a
significant reduction in saturated fat consumption
(table III). Whole milk consumption decreased from
280 to 150 kg/person/year and butter and margarine
from 21 6 to 16 8 kg/person/year. Low fat milk became
available in 1982 and low fat butter and margarine also
became available during the study period, accounting
TABLE IlI-Consumption ofdairv products and marganrne (kglpersonl
year)
Year
1970 1975 1980 1985 1988
Whole milk 280-0 230-0 200-0 170 0 150-0
Low fat milk 21-0 34-0
Skimmed milk 5-0 6-0 7-0 8-0 12-0
Cream 4-5 6-0 5-8 6-3 6-7
Cheese 4-2 5-4 6-0 8-8 10-5
Butter/margarine 21-6 18 4 19-8 17-6 16 8
Total fat from these products 31-4 27-9 27-6 26-0 25-3
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Men aged 45-64
1_4- o Ischaemic heart disease mortality1-4- * Risk from three major risk factors
12
50.8-
0-6-
a: -
0-4-
0-2-
1968 1970 1975 1980 1985 1988
Women aged 45-64
o Ischaemic heart disease mortality
1-4 0 Risk from three major risk factors
1-2-
108
0.6 -
0-4
0-2-
1968 11970 1 975 1980 1 985 1988
Year
FIG 3-Observed death rates from ischaemic heart disease and
calculated risks explained by major risk factors (smoking, systolic
blood pressure, serum cholesterol concentration) relative to 1968 (men)
and 1969 (women). Bars are 95% confidence intervals
for part of the reduction in fat from these products.
Though sales of cheeses and cream increased, there
was an overall reduction of 20% in dietary fat from all
dairy products and margarine-that is, from a total of
86 to 69 g/person/day.
Total meat sales did not change appreciably during
the period. Nevertheless, there was a trend towards
purchase of leaner varieties such as chicken and lean
beef and away from the traditional fatty lamb and
mutton.
Reliable data on fish consumption are lacking.
According to a household study from 1985, however,
Icelanders purchased about 119 kg of whole fish per
person yearly,'7 which thereby ranked them as the
largest consumers of fish in Europe. Though sales of
most fatty foods declined during this period, sales of
carbohydrate rich foods such as bread, fruit, and
vegetables rose, and so did the sales of soft drinks and
fruit juices.'7 Clearly, during the period studied the
overall composition of the Icelandic diet changed
towards more carbohydrates and fewer saturated fats.
Discussion
Ongoing population surveys in Iceland offer an
opportunity to explore time trends in risk factor levels
and compare them with the mortality and morbidity
due to ischaemic heart disease. Total mortality from
ischaemic heart disease decreased significantly after
1985 (17% in men, 12% in women). At the same
time registrations of myocardial infarction in Iceland
(MONICA project 1981-6) showed a significant
decline in the incidence rate, suggesting that the
reduction in mortality was largely due to a reduction in
incidence. The case fatality rate did not decrease
significantly. This study did not include analysis of
changes in management of ischaemic heart disease
during 1968-88, so their effect cannot be estimated.
It is possible that changes in death rates attributed to
particular causes may be an artefact of changes in
classification techniques and diagnostic fashions. The
most likely shift would be into other categories of
cardiovascular mortality (ICD codes 390-448). That
the recent trend in total cardiovascular mortality was
similar to the trend in mortality from ischaemic heart
disease, however, suggests that the decline was real.
Furthermore, after 1966-70 the life expectancy of 40
year old men and women in Iceland increased by
1 8 and 3-0 years respectively. According to official
statistics the proportionate mortality due to ischaemic
heart disease decreased from 35 3% to 30 5% in men
and from 229% to 19 5% in women.
The levels of all three risk factors studied decreased
over time. The Reykjavik study showed the multiplica-
tive effects of these factors on risk. The factors them-
selves were nearly uncorrelated and explained about
75% of all deaths from ischaemic heart disease (see
coefficients in table 11)6 (unpublished results). Accord-
ing to the Cox model a decrease of 0-4 mmol/l (6%) in
the cholesterol concentration in men should decrease
the risk by 14% and a reduction of0 75 mmol/l (I0 5%)
in the cholesterol concentration in women should
decrease the risk by 17%. Most other studies have
indicated that a 1% reduction in cholesterol values
decreases the risk of ischaemic heart disease by 2% in
men. 18
Altered food habits in Iceland coincide strongly with
the observed decline in serum cholesterol concen-
trations. Decreased consumption of dairy fat and
margarine alone would be expected to lower the serum
cholesterol concentration by 0-3 mmol/l according to
the equation of Keys et al.'9 In addition, consumption
of meat fat has certainly decreased as more carcase fat
is discarded during production and leaner meats
have become available. Exact figures regarding these
changes are, however, not available. Cholesterol values
would accordingly be expected to have decreased more
than 0-3 mmol/l as a result of changes in diet, as indeed
they had (0 42 mmol/l among men, 0 75 mmol/l among
women). The more dramatic fall in cholesterol concen-
trations among women was unexplained, but possibly
women changed their diet to a greater extent.
The fall in blood pressure came somewhat later, and
the decrease in smoking was not apparent until after
1980.
The multiplicative effect of relatively moderate
changes in all three risk factors adds up to a 34-37%
decrease in risk in the age group 45-64 years. The
calculated decline in risk by 1988 coincides with the
observed fall in ischaemic heart disease death rates in
the same age groups. This is consistent with the
hypothesis that most of the decline in ischaemic heart
disease in Iceland over the period can be explained by
the changes observed in the three major risk factors.
Little is known about the lag between changes in risk
factors in the population and changes in the incidence
of ischaemic heart disease. In this study the changes in
risk factors and ischaemic heart disease incidence were
coincident in women whereas in men there was a lag of
several years.
Studies from Great Britain, United States, Australia,
and New Zealand have estimated that 30-75% of the
observed decline in death rates from ischaemic heart
disease was related to changes in lifestyle resulting in a
fall in the three major risk factors.20-23 Most of the
studies were based on mortality statistics, with little or
no direct information about the individual changes in
risk factor pattern, which our Icelandic surveys have
offered an opportunity to observe.
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Excess mortality associated
with the HIV epidemic in
England and Wales
Anna McCormick
Increased mortality unattributed to but probably
associated with HIV infection has been reported in the
United States. 1-3 Excess mortality has also been
identified among HIV positive haemophiliac patients
in the United Kingdom.4 A study of trends in mortality
between 1984 and 1987 suggested that the increase
found among single men was probably related to HIV
infection.' In this paper I examine the number of
excess deaths in England and Wales in 1988 and 1989
and relate this to the HIV epidemic.
Patients, methods, and results
Draft death entries on which one of 95 selected
conditions was stated to be the cause of death were
identified at the Office of Population Censuses and
Surveys (OPCS). These causes were selected because
they had been mentioned on death certificates of
people known to have had AIDS. They included 86
medical causes, including AIDS and HIV infection
(International Classification of Diseases (ICD) code
279.1). Nine external causes were also included,
covering drug dependence and poisoning due to
various substances. The number of excess deaths was
estimated by subtracting the number of deaths in
1984 from the number in each subsequent year after
adjusting for population changes within each five year
age group. The numbers of reports of people who
died with AIDS and HIV positive people who died
without developing an AIDS indicator disease
were obtained from the Public Health Laboratory
Service Communicable Disease Surveillance Centre
(CDSC).
There were 2505 deaths due to one of the 95 causes
among single men aged 15-54 in 1989-498 (25%)
above the number expected based on rates in 1984.
AIDS or HIV infection was stated as the cause of death
for only 233 (47%) of the excess deaths, leaving 265
(53%) probable HIV related deaths attributed to some
other cause.
Analysis of the 86 medical causes alone showed that
there were 1362 deaths among single men aged 15-54 in
1989-379 (39%) above the number expected-233
(61%) of which were attributed to AIDS or HIV
infection. There was no similar increase among men of
other marital states or among women. The increase was
greatest among single men aged 30-44 and in the
Thames health regions.
Analysis of the nine external causes alone, however,
showed a different picture. Among single men aged
15-54 there were 1143 deaths in 1989, 119 (12%) above
the number expected compared with 1984. Smaller
increases also occurred among men of other marital
states and among women. The increase among single
men was greatest among those aged 15-24 and was
fairly evenly distributed across the country, suggesting
that factors other than the HIV epidemic may have
contributed.
In all, 376 deaths among HIV positive single men
aged 15-54 were reported to CDSC in 1989, an excess
of 347 compared with 1984. If the total number of
deaths reported to OPCS is used as the denominator
70% were reported to CDSC in 1989. However, if
deaths reported to OPCS due to the 86 medical causes
alone is used 92% were reported to CDSC.
Comment
The associations with age, sex, marital state, and
geographic location suggest that the continuing increase
in the number of deaths due to the 86 HIV related
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